Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker
Authors:
- Marina DevetziMDMarina Devetzi
- Andreas ScorilasASAndreas Scorilas
- Evangelos TsiambasETEvangelos Tsiambas
- Mansoureh SameniMSMansoureh Sameni
- Stelios FotiouSFStelios Fotiou
- Bonnie F. SloaneBSBonnie F. Sloane
- Maroulio TalieriMTMaroulio Talieri
- 1 March 2009
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 112 (3) , 531-536
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasionBiochimie, 2008
- Endometrial carcinoma expresses an increased cathepsin B/D ratioGynecologic Oncology, 2008
- Molecular and Pathologic Aspects of Endometrial CarcinogenesisJournal of Clinical Oncology, 2006
- multifunctional enzymes in cancerNature Reviews Cancer, 2006
- Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary CancerClinical Cancer Research, 2005
- Cysteine cathepsins in human cancerBiological Chemistry, 2004
- Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer—MMP-9 correlates to the grade and the stageGynecologic Oncology, 2004
- Proteases, Extracellular Matrix, and CancerThe American Journal of Pathology, 2004
- Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinomaCancer Letters, 2004
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958